Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a biotechnology company that strives to accelerate
the discovery, development and commercialization of new medicines. To ensure you have the latest
clinical data, including links to our pivotal trial publications, and important product information, visit our
website. https://www.cabometyxhcp.com

Dosing and Administration Guide Download File
Now Approved Announcement Download File

Cabometyx Website Open link in new window
Exelixis Access Services (EASE) Open link in new window
Product Resources Open link in new window
Full Prescribing Information Open link in new window